New England Journal of Medicine · 1977 · 143 citations · 29 references
MedicineEndocrinologyInternal MedicineClinical BiochemistryClinical ImmunologyDiabetologyDiabetes ControlDiabetes ManagementDiabetes MellitusGlycemic ControlHypoglycemia ManagementInsulin TherapyAnti-insulin AntibodiesAntibodiesBinding AntibodiesC-peptide MeasurementDiabetes DiagnosisHypoglycemia Diagnostic EvaluationHypoglycemia In DiabetesInsulin Measurement
In seven patients with factitious hypoglycemia due to the surreptitious injection of insulin, we made the diagnosis by measurements of plasma insulin and C-peptide immunoreactivity (in seven patients), facilitated by the finding of circulating insulin-binding antibodies (in two patients). The simultaneous demonstration of low plasma glucose, high immunoreactive insulin and suppressed C-peptide immunoreactivity represents a triad of results pathognomonic of exogenous insulin administration. Determination of plasma free C-peptide and free insulin permitted patients with high titers of insulin antibodies, including those with a history of insulin-treated diabetes, to be studied and diagnosed in a way similar to that in subjects who had no circulating insulin antibodies.
29
Characteristics of the Human Lymphocyte Insulin Receptor
James R. Gavin, Phillip Görden, Jesse Roth et al. · Journal of Biological Chemistry · 1973 · 318 citations · Full text
Determination of free and total insulin and C-peptide in insulin-treated diabetics
H. Kuzuya, P.M. Blix, David L. Horwitz et al. · Diabetes · 1977 · 170 citations